⌘K

Login Start Free

Home/Filings/4/0001437749-14-000043

4//SEC Filing

TearLab Corp 4

Accession 0001437749-14-000043

CIK 0001299139operating

View on SEC.gov Company Profile

Filed

Jan 1, 7:00 PM ET

Accepted

Jan 2, 4:02 PM ET

Size

15.6 KB

Accession

0001437749-14-000043

Insider Transaction Report

Form 4

Period: 2014-01-02

TearLab CorpTEAR

Director

Transactions

Exercise/Conversion
Common Stock
2014-01-02$3.12/sh+3,376$10,533→ 6,876 total
Exercise/Conversion
Common Stock
2014-01-02$2.11/sh+1,076$2,270→ 8,500 total
Exercise/Conversion
Stock Option (right to buy)
2014-01-02−1,076→ 3,710 total
Exercise: $2.11Exp: 2020-07-01→ Common Stock (1,076 underlying)
Exercise/Conversion
Stock Option (right to buy)
2014-01-02−548→ 0 total
Exercise: $2.59Exp: 2020-04-01→ Common Stock (548 underlying)
Exercise/Conversion
Common Stock
2014-01-02$2.59/sh+548$1,419→ 7,424 total
Sale
Common Stock
2014-01-02$9.47/sh−5,000$47,344→ 3,500 total
Exercise/Conversion
Stock Option (right to buy)
2014-01-02−3,376→ 0 total
Exercise: $3.12Exp: 2018-12-12→ Common Stock (3,376 underlying)

Footnotes (5)

[F1]The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on April 2, 2013.
[F2]Represents the weighted average share price of an aggregate total of 5,000 shares sold in the price range of $9.27 to $9.53 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
[F3]Twenty-five percent (25%) of the shares subject to the option vested and became exercisable on April 12, 2010, and, thereafter, one thirty sixth (1/36th) of the remaining shares subject to the option vested and became exercisable in equal monthly installments over the next thirty six (36) months.
[F4]One hundred percent of the shares subject to the option vested and became exercisable on April 1, 2010.
[F5]One hundred percent of the shares subject to the option vested and became exercisable on July 1, 2010.

Documents

1 file

4
rdgdoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

TearLab Corp

CIK 0001299139

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001299139

Filing Metadata

Form type: 4
Filed: Jan 1, 7:00 PM ET
Accepted: Jan 2, 4:02 PM ET
Size: 15.6 KB

View on SEC.gov